Tag: avadel pharmaceuticals

November 25, 2019

Avadel Pharma Reaches Enrollment Target in REST-ON Trial

The company announced that its Phase 3 REST-ON Phase 3 trial has enrolled 205 patients who have narcolepsy and cataplexy,...
May 22, 2019

Avadel Pharmaceuticals Receives FDA Acceptance for New Drug Application

Avadel Pharmaceuticals (NASDAQ:AVDL) has announced that the US Food and Drug Administration (FDA) has granted the company new drug application...
November 5, 2018

Avadel Pharmaceuticals Reports Third Quarter 2018 Financial Results

Avadel Pharmaceuticals (NASDAQ:AVDL) has announced its financial results for Q3 2018. As quoted in the press release: Mike Anderson, Avadel’s...
October 7, 2018

5 Top Weekly NASDAQ Biotech Stocks: vTv Leads with 374 Percent

vTv Therapeutics, Trevena, Cyclacel Pharmaceuticals, Paratek Pharmaceuticals and Avadel Pharmaceuticals were last week's top gainers on the NASDAQ Biotechnology Index.
September 28, 2018

Avadel Pharmaceuticals Announces Journal of Urology Publication of Phase 3 Data on NOCTIVA

Avadel Pharmaceuticals (Nasdaq:AVDL), a company focused on providing innovative medicines for chronic urological, central nervous system, and sleep disorders, announced...